Physician profile
Jarred Abel
NPI 1649488560
$3,160.53
in general payments reported to CMS, 2019-2025
10 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,768 · 2020: $234 · 2021: $179 · 2022: $119 · 2023: $217 · 2024: $389 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $2,564.32 | 2019-2025 | |
| Geistlich Pharma, North America, INC. | $159.89 | 2025 | Biomaterials |
| Align Technology, INC. | $107.14 | 2023 | Itero Element 5d Plus |
| Zimvie INC. | $66.40 | 2022-2025 | |
| Nobel Biocare USA | $65.06 | 2019 | |
| Salvin Dental Specialties, INC. | $52.71 | 2019 | |
| Keystone Dental INC. | $45.11 | 2022 | |
| Carestream Dental, LLC | $44.00 | 2019-2020 | |
| Biohorizons Implant Systems INC. | $34.82 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $21.08 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jarred Abel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.